Amarin AMRN Stock
Amarin Price Chart
Amarin AMRN Financial and Trading Overview
| Amarin stock price | 14.11 USD |
| Previous Close | 14.26 USD |
| Open | 14.28 USD |
| Bid | 12.22 USD x 100 |
| Ask | 16.46 USD x 100 |
| Day's Range | 13.98 - 14.28 USD |
| 52 Week Range | 12.96 - 20.9 USD |
| Volume | 18.45K USD |
| Avg. Volume | 73.33K USD |
| Market Cap | 294.41M USD |
| Beta (5Y Monthly) | 0.802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12 USD |
AMRN Valuation Measures
| Enterprise Value | -6262387 USD |
| Trailing P/E | N/A |
| Forward P/E | 14.32653 |
| PEG Ratio (5 yr expected) | 0.81 |
| Price/Sales (ttm) | 1.5808492 |
| Price/Book (mrq) | 0.6647098 |
| Enterprise Value/Revenue | -0.034 |
| Enterprise Value/EBITDA | 0.297 |
Trading Information
Amarin Stock Price History
| Beta (5Y Monthly) | 0.802 |
| 52-Week Change | -7.28% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 20.9 USD |
| 52 Week Low | 12.96 USD |
| 50-Day Moving Average | 14.81 USD |
| 200-Day Moving Average | 15.19 USD |
AMRN Share Statistics
| Avg. Volume (3 month) | 73.33K USD |
| Avg. Daily Volume (10-Days) | 55.65K USD |
| Shares Outstanding | 20.97M |
| Float | 19.01M |
| Short Ratio | 5.54 |
| % Held by Insiders | 37.17% |
| % Held by Institutions | 22.51% |
| Shares Short | 513.2K |
| Short % of Float | 2.48% |
| Short % of Shares Outstanding | 2.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -14.56% |
| Operating Margin (ttm) | -28.35% |
| Gross Margin | 41.95% |
| EBITDA Margin | -11.32% |
Management Effectiveness
| Return on Assets (ttm) | -2.31% |
| Return on Equity (ttm) | -5.97% |
Income Statement
| Revenue (ttm) | 186.23M USD |
| Revenue Per Share (ttm) | 8.92 USD |
| Quarterly Revenue Growth (yoy) | -42.00000000000000000000000000000000% |
| Gross Profit (ttm) | 78.14M USD |
| EBITDA | -21095000 USD |
| Net Income Avi to Common (ttm) | -27124000 USD |
| Diluted EPS (ttm) | -1.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 314.65M USD |
| Total Cash Per Share (mrq) | 14.9 USD |
| Total Debt (mrq) | 7.18M USD |
| Total Debt/Equity (mrq) | 1.62 USD |
| Current Ratio (mrq) | 3.671 |
| Book Value Per Share (mrq) | 21.122 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.57M USD |
| Levered Free Cash Flow (ttm) | -5569250 USD |
Profile of Amarin
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | One Central Plaza |
| ZIP | D02 K7K5 |
| Phone | 353 0 166 99020 |
| Website | https://www.amarincorp.com |
| Industry | Drug Manufacturers - General |
| Sector(s) | Healthcare |
| Full Time Employees | 80 |
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Q&A For Amarin Stock
What is a current AMRN stock price?
Amarin AMRN stock price today per share is 14.11 USD.
How to purchase Amarin stock?
You can buy AMRN shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amarin?
The stock symbol or ticker of Amarin is AMRN.
Which industry does the Amarin company belong to?
The Amarin industry is Drug Manufacturers - General.
How many shares does Amarin have in circulation?
The max supply of Amarin shares is 20.97M.
What is Amarin Price to Earnings Ratio (PE Ratio)?
Amarin PE Ratio is now.
What was Amarin earnings per share over the trailing 12 months (TTM)?
Amarin EPS is -1.2 USD over the trailing 12 months.
Which sector does the Amarin company belong to?
The Amarin sector is Healthcare.
Amarin AMRN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25872.56 USD — |
+1.97
|
5.94B USD — | 25420.35 USD — | 25879.92 USD — | — - | 5.94B USD — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
7021.77 USD — |
-0.29
|
— — | 6964.2 USD — | 7060.18 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2230.58 USD — |
+1.67
|
— — | 2184.88 USD — | 2230.75 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6430.33 USD — |
-0.35
|
— — | 6381.13 USD — | 6469.08 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1239.62 USD — |
+0.44
|
— — | 1233.81 USD — | 1244.91 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31932.75 USD — |
+2.01
|
— — | 31362.39 USD — | 31942.4 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}
